Cenobamate (XCOPRI) visual mnemonics



Excerpt from Cafer's Mood Stabilizers and Antiepileptics, available on Amazon



Cenobamate (XCOPRI)
“Cinnabon Ex-couple”
Pronunciation: sen oh BAM ate / EX cop ree
cenobamate (Xcopri) visual mnemonic from Cafer's Psychopharmacology (CaferMed)
 ❖ Antiepileptic
 ❖ GABAA modulator
 ❖ DEA Schedule V
 FDA approved for:
  ❖ Partial-onset seizures (adults)
  Cenobamate (Xcopri) is the newest antiepileptic drug (AED), released in 2020. There are some serious risks, side effects and kinetic drug/drug interactions. 
 
Dosing is similar to lamotrigine (Lamictal), with a slow titration to a recommended dose of 200 mg over 11 weeks. As with lamotrigine, maximum dose is 400 mg. The slow titration is necessary to avoid Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), also known as multiorgan hypersensitivity. There were no cases of DRESS among over 1,000 patients with adherence to the slow titration schedule.

Cenobamate shortens QT interval and is contraindicated with Familial Short QT Syndrome. QTc interval under 300 is dangerous. 
 
Dose-dependent side effects are common (36% at 200 mg; 57% at 400 mg) including somnolence/fatigue, dizziness, diplopia/blurred vision, cognitive impairment, and headaches. Dropout rates were 11%, 9%, and 21% respectively for patients randomized to receive Cenobamate 100 mg/day, 200 mg/day, and 400 mg/day (versus 4% for placebo).
 
Cenobamate is a Schedule V (five) controlled substance (least restrictive) because euphoric feelings are possible at high doses. The risk of psychiatric adverse effects appears to be about 1 in 333. All antiepileptics have a risk of suicidal ideation. In the clinical trial there were 4 suicides among over 25,000 patients, versus none for 16,000 patients on placebo. Causation was not established. A withdrawal syndrome was observed with sudden discontinuation, including tremor, mood disturbance, and insomnia. 
 
At 400 mg (maximum dose), liver enzymes were elevated with ALT greater than 3x upper limit of normal in almost 3% of patients. Cenobamate may also elevate serum potassium. 
 
Dosing: The initial dose is 12.5 mg QD, to be titrated over 11 weeks to the recommended maintenance dose of 200 mg QD; May take with or without food, at any (consistent) time of day; The recommended titration schedule should not be exceeded; Maximum dose is 400 mg QD (200 if mild/moderate hepatic impairment); To discontinue, taper over at least 2 weeks. 

 Dynamic interactions:
 ❖ Sedation/CNS depression
 ❖ QT shortening
 ❖ Hypokalemia
 ❖ Liver enzyme elevation
Kinetic interactions: 
❖ 2C19 inHibitor ⁃ Increases levels of phenytoin (Dilantin) by 75%, requiring dose adjustment ⁃ Increases levels of phenobarbital (Luminal) and active metabolite of clobazam (Onfi) 
❖ 3A4 inDucer ⁃ Decreases levels of hormonal contraceptives and carbamazepine (Tegretol) 
❖ UGT inDucer ⁃ Decreases levels of lamotrigine (Lamictal)
CYP450 interactions of cenobamate (Xcopri) by Jason Cafer MD

Compare pharmacy prices for
Xcopri Titration pack of 12.5mg/25mg package (1 qty)
Costco97.18
Medicine Shoppe100.31
Rite Aid102.10
Compare prices for Xcopri & other drugs at GoodRx




Copyright 2020, CaferMed LLC





































Comments











Post a Comment























Popular posts from this blog









Lithium




















Image







Excerpt from  Cafer's Mood Stabilizers and Antiepileptics Mood stabilizer      Neuroprotectant   FDA approved for: ❖ Acute mania     ❖ Bipolar disorder (maintenance) Used off-label for:     ❖ Depression     ❖ Suicidal ideation     ❖ Dementia     ❖ Alcoholism     ❖ Agitation     ❖ Headaches     ❖ Neutropenia     ❖ SIADH     ❖ Longevity  Lithium is the gold standard treatment for bipolar disorder. It is superior to all medications at preventing suicide, reducing risk 5-fold for individuals with recurrent unipolar depression and 6-fold for those with bipolar disorder (Tondo et al, 2016).  It works by several mechanisms that are not entirely understood.  Lithium is an element on the periodic table, classified as an alkali metal. Its atomic number is 3, making it the 3rd lightest element. Lithium was one of the first three elements in existence with the big bang (along with helium and hydrogen) over 13 billion years ago.  Lithium citrate was added to 7-Up (originally known as Bib-Label 








Read more










Lumateperone (Caplyta)




















Image







Available on Amazon:  Cafer's Mood Stabilizers and Antiepileptic Drugs        Lumateperone (CAPLYTA) Pronunciation:  luma TEP er ohn / cap LIE ta  “’Lum inated  Cap lighter” Antipsychotics are represented  with spooky mascots. Year of US release: 2020  ❖ Antipsychotic (SGA) ❖ D2 antagonist - ⇩DA ❖ 5-HT2A antagonist - ⇧DA ❖ Glutamate modulator  FDA-approved for:  ❖ Schizophrenia  Lumateperone is a new antipsychotic that purportedly modulates glutamate  in addition to the usual SGA mechanism of blocking D2 and 5-HT2A receptors. However, the official prescribing information does not mention glutamate, suggesting the FDA saw insufficient evidence for lumateperone being a first-in-class novel antipsychotic. It appears to be equally effective as risperidone (Risperdal) with fewer side effects other than sedation (Citrome, 2016).  Lumateperone’s D2 receptor occupancy is lower than most other antipsychotics. This means extrapyramidal side effects are unlikely. The other antipsychotics with








Read more